AETHLON MEDICAL, INC. (AEMD) Free cash flow 2017–2026
AETHLON MEDICAL, INC. (AEMD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$7.0MFY2026 · since FY2017: -$3.5M → -$7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$7.0M | +8.4% |
| FY2025 | -$7.6M | +26.3% |
| FY2024 | -$10.4M | +9.3% |
| FY2023 | -$11.4M | -13.2% |
| FY2022 | -$10.1M | -48.2% |
| FY2021 | -$6.8M | -27.6% |
| FY2020 | -$5.3M | -24.6% |
| FY2019 | -$4.3M | -9.1% |
| FY2018 | -$3.9M | -11.7% |
| FY2017 | -$3.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AEMD financial trends
AEMD RevenueAEMD Net incomeAEMD Net marginAEMD Gross profitAEMD Gross marginAEMD Operating incomeAEMD Operating marginAEMD Operating cash flowAEMD Capital expendituresAEMD Return on equityAEMD Stock buybacksAEMD Dividends paidAEMD Total assetsAEMD Total liabilitiesAEMD Shareholders’ equityAEMD overview →